% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • larshansson18 larshansson18 Feb 17, 2009 7:05 AM Flag

    OPEN LETTER to EpiCept Managament

    Please look at my text, so we that we might have a dialogue.

    I give you another point (to the others above):
    Hellstran said in an interview that the Co gave him the best statisticians for the application process. Jack and the rest of the management did what Maxim could not.

    That have added temendous value to the Co. Will see what will come out of the upcoming 3 fas III studies versus the other diagnose for Ceplene.
    NP-1, Azixa and Epc 2407 goes our way.

    I do not assume that a CEO for a research CO a priori is the best for a cash flow dito. Only time will tell. He has right now made many wise decisions ( for example San Diego - the new PP)
    If Hellstrand will do another race with the Co I find that more interesting than your anger. Do you find that an odd standpoint?

    No matter the pre-history case of yours, I'll hope you will be more successful in the future.

    Best regards,

1.7828+0.1328(+8.05%)3:59 PMEDT